维普中文期刊产品整合服务
106篇 您的检索式:作者名="Hardan"
    题名 作者 年代 出处 被引量
1Therapy with thalidomide in refractory multiple myeloma patients - the revival of an old drug 显示文摘Keller A Raanani P Hardan I 2000Br THaematol2000,108,:1
2Neuropsychiatric problems in tuber-ous sclerosis complex显示文摘Asato MR Hardan AY 2004J Child Neurol?20042004,,:1
3Therapy with thalidomide in refractory multiple myeloma patients:the revival of an old drug显示文摘Kneller A Raanani P Hardan I 2000Br J Haematol2000,108,2:1
4Yttrium-90–ibritumomab tiuxetan (Zevalin) combined with high-dose BEAM chemotherapy and autologous stem cell transplantation for chemo-refractory aggressive non-Hodgkin’s lymphoma显示文摘Avichai Shimoni S. Tzila Zwas Yakov Oksman Izhar Hardan Noga Shem-Tov Ronit Yerushalmi Abraham Avigdor Isaac Ben-Bassat Arnon Nagler 2007Experimental Hematology2007,,4:1
5Therapy with thalidomide in refractory multiple myeloma patients- the revival of an old drug显示文摘 Raanani P Hardan I 2000Br J Haematol2000,108,2:1
6An MRI study of increased cortical thickness in autism 显示文摘Hardan AY Muddasani S Vemulapalli M 2006Am J Psychiatry2006,163,7:1
7CXCR4 antagonist 4F-benzoyl-TN14003 inhibits leukemia and multiple myeloma tumor growth显示文摘Katia Beider Michal Begin Michal Abraham Hanna Wald Ido D. Weiss Ori Wald Eli Pikarsky Evelyne Zeira Orly Eizenberg Eithan Galun Izhar Hardan Dan Engelhard Arnon Nagler Amnon Peled 2011Experimental Hematology2011,,3:1
8Therapy with thalidomide in refractory multiple myeloma patients-the revival of an old drug 显示文摘Kneller A Raanani P Hardan I 2000Br J Haematol2000,108,2:1
9Therapy with thalidomide in refractory Multiple myeloma patients-the revival of an old drug显示文摘 Raanani P Hardan I 2000Br J Nematol2000,108,2:1
10Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning:the role of dose intensity显示文摘Shimoni A Hardan I Shem-Tov N 0,,:1
11Therapy with thalidomidein refractory multiple myeloma patients-the revival of an olddrug显示文摘Kneller A Raanani P Hardan I 2000Br J Haematol2000,108,2:1
12Therapy with thalidomide in refractory multiple myeloma patients-the revival of an old drug显示文摘Kneller A Raanani P Hardan I 2000Br J Haematol2000,108,2:1
13Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: fiudarabine/ melphalan is associated with higher irlcidence of acute graft- versus-host disease and non-relapse mortality and lower incidence of relapse than fiudarabine/busulfan 显示文摘Shimoni A Hardan I Shem-Tov N 2007Leukemia2007,21,10:1
14Therapy with thalidomide in refractory multiple myeloma patients2 the revival of an old drug 显示文摘Kneller A Raanani P Hardan I 2000Br J Haematol2000,108,8:1
15Therapy with thalidomide in refractory multiple myeloma patients the revival of an old drug显示文摘Kneller A Raanani P Hardan I 2000Br J Haematol2000,108,2:1
16Therapy with thalidomide in refractory mulpiple myeloma patients the revival of an old drug显示文摘Kneller A Raanani P Hardan I 2000Br J Haematol2000,108,:1
17Therapy with thalido-mide in refractory multiple myeloma patients-the revival of anold drug显示文摘Kneller A Raanani P Hardan I 0,,:1
18Therapy with thalidomide in refractory muhiple myeloma patients the revival of an old drug 显示文摘Kneller A Rasuda P Hardan I 2000Br J Hoemato12000,108,:1
19The role of irradiation of the internalmammary lymph nodes in high-risk stage II to III A breast cancerpatients after high dose chemotherapy: a prospective sequential nonrandomized study显示文摘Salomon SM Rizel S Hardan I 2003J Clin On- col2003,21,14:1
20Therapy with thalidomide in refractory multiple myeloma patients-the revival of an old drug显示文摘Kneller A Raanani P Hardan I 2000Br J Haematol2000,108,2:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费